Literature DB >> 27564867

Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology?

Jennifer S Gewandter1, Robert H Dworkin1, Nanna B Finnerup2, Nimish A Mohile3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27564867      PMCID： PMC6784316          DOI： 10.1097/j.pain.0000000000000653

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   7.926


× No keyword cloud information.
  21 in total

Review 1.  Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.

Authors:  Marco Sisignano; Ralf Baron; Klaus Scholich; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2014-11-04       Impact factor: 42.937

2.  Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysis.

Authors:  Robert H Dworkin; Dennis C Turk; Sarah Peirce-Sandner; Hua He; Michael P McDermott; John T Farrar; Nathaniel P Katz; Allison H Lin; Bob A Rappaport; Michael C Rowbotham
Journal:  Neurology       Date:  2013-05-22       Impact factor: 9.910

3.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

4.  Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.

Authors:  Anna-Liisa Kautio; Maija Haanpää; Arto Leminen; Eija Kalso; Hannu Kautiainen; Tiina Saarto
Journal:  Anticancer Res       Date:  2009-07       Impact factor: 2.480

5.  Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.

Authors:  E A Calhoun; E E Welshman; C-H Chang; J R Lurain; D A Fishman; T L Hunt; D Cella
Journal:  Int J Gynecol Cancer       Date:  2003 Nov-Dec       Impact factor: 3.437

6.  Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.

Authors:  Julie E Hammack; John C Michalak; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; Gamini S Soori; Maria Tria Tirona; Kendrith M Rowland; Philip J Stella; Joanne A Johnson
Journal:  Pain       Date:  2002-07       Impact factor: 6.961

7.  Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

Authors:  Ravi D Rao; John C Michalak; Jeff A Sloan; Charles L Loprinzi; Gamini S Soori; Daniel A Nikcevich; David O Warner; Paul Novotny; Leila A Kutteh; Gilbert Y Wong
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

8.  Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

Authors:  Ravi D Rao; Patrick J Flynn; Jeff A Sloan; Gilbert Y Wong; Paul Novotny; David B Johnson; Howard M Gross; Samer I Renno; Mohammed Nashawaty; Charles L Loprinzi
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

Review 9.  Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

Authors:  Dawn L Hershman; Christina Lacchetti; Robert H Dworkin; Ellen M Lavoie Smith; Jonathan Bleeker; Guido Cavaletti; Cynthia Chauhan; Patrick Gavin; Antoinette Lavino; Maryam B Lustberg; Judith Paice; Bryan Schneider; Mary Lou Smith; Tom Smith; Shelby Terstriep; Nina Wagner-Johnston; Kate Bak; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

Review 10.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Authors:  Andy Trotti; A Dimitrios Colevas; Ann Setser; Valerie Rusch; David Jaques; Volker Budach; Corey Langer; Barbara Murphy; Richard Cumberlin; C Norman Coleman; Philip Rubin
Journal:  Semin Radiat Oncol       Date:  2003-07       Impact factor: 5.934
View more
  10 in total

1.  Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.

Authors:  Paola Alberti; Emanuela Rossi; Andreas A Argyriou; Haralabos P Kalofonos; Chiara Briani; Mario Cacciavillani; Marta Campagnolo; Jordi Bruna; Roser Velasco; Marina E Cazzaniga; Diego Cortinovis; Maria G Valsecchi; Guido Cavaletti
Journal:  Support Care Cancer       Date:  2018-03-29       Impact factor: 3.603

Review 2.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

3.  Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data.

Authors:  Ellen M Lavoie Smith; Tanima Banerjee; James J Yang; Celia M Bridges; Paola Alberti; Jeff A Sloan; Charles Loprinzi
Journal:  Cancer Nurs       Date:  2019 May/Jun       Impact factor: 2.592

4.  Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification.

Authors:  Praveen Anand; Enas Elsafa; Rosario Privitera; Kalnisha Naidoo; Yiangos Yiangou; Philippe Donatien; Hani Gabra; Harpreet Wasan; Laura Kenny; Amin Rahemtulla; Peter Misra
Journal:  J Pain Res       Date:  2019-07-03       Impact factor: 3.133

Review 5.  Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review.

Authors:  Deborah Lee; Grace Kanzawa-Lee; Robert Knoerl; Gwen Wyatt; Ellen M Lavoie Smith
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Oct-Dec

Review 6.  Physiotherapy for people with painful peripheral neuropathies: a narrative review of its efficacy and safety.

Authors:  Tom Jesson; Nils Runge; Annina B Schmid
Journal:  Pain Rep       Date:  2020-09-23

7.  Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series.

Authors:  Stacy D'Andre; Sean McAllister; Jasdeepa Nagi; Karthik V Giridhar; Eduardo Ruiz-Macias; Charles Loprinzi
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

Review 8.  Endoplasmic Reticulum Stress in Chemotherapy-Induced Peripheral Neuropathy: Emerging Role of Phytochemicals.

Authors:  Yugal Goel; Raghda Fouda; Kalpna Gupta
Journal:  Antioxidants (Basel)       Date:  2022-01-28

9.  In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.

Authors:  Ellen M Lavoie Smith; Robert Knoerl; James J Yang; Grace Kanzawa-Lee; Deborah Lee; Celia M Bridges
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

Review 10.  Recent advances in understanding chemotherapy-induced peripheral neuropathy.

Authors:  Richard Gordon-Williams; Paul Farquhar-Smith
Journal:  F1000Res       Date:  2020-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.